Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2008 February;60(1) > Minerva Ginecologica 2008 February;60(1):77-82

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS  POLYCISTIC OVARY SYNDROME 

Minerva Ginecologica 2008 February;60(1):77-82

Copyright © 2008 EDIZIONI MINERVA MEDICA

language: English

Role of metformin in patients with polycystic ovary syndrome: the state of the art

Palomba S. 1, Falbo A. 1, Russo T. 1, Orio F. 2, Tollino A. 3, Zullo F. 1

1 Department of Gynecology and Obstetrics, Magna Graecia University of Catanzaro, Catanzaro, Italy 2 Endocrinology, Parthenope University of Naples, Naples, Italy 3 Department of Gynecology and Obstetrics, Parthenope University of Naples, Naples, Italy


PDF


Metformin, an insulin sensitizer widely used for the treatment of patients with type-2 diabetes mellitus (DM), was recently introduced in the clinical practice to treat women with polycystic ovary syndrome (PCOS). The aim of the current review was to evaluate the current role of metformin in the treatment of the PCOS-related disorders. The Authors analyze here the administration of metformin for treating the ovarian dysfunction due to PCOS, and show the evidences available in literature regarding its alternative uses.

top of page